Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting
CONCLUSIONS: These findings suggest that, in a real-world setting, when used concurrently with antipsychotic medication, methylphenidate, amphetamines and atomoxetine may be safer than generally believed in individuals with psychotic disorders.PMID:38044665 | DOI:10.1192/bjp.2023.149 (Source: The British Journal of Psychiatry for Mental Science)
Source: The British Journal of Psychiatry for Mental Science - December 4, 2023 Category: Psychiatry Authors: Olivier Corbeil S ébastien Brodeur Josiane Courteau Laurent B échard Maxime Huot-Lavoie Elaine Angelopoulos Samanta Di Stefano Erica Marrone Alain Vanasse Marie-Jos ée Fleury Emmanuel Stip Alain Lesage Ridha Joober Marie-France Demers Marc-Andr é Roy Source Type: research
